NanoGroup S.A. has filed an IPO in the amount of PLN 45 million. Proceeds will be used by NanoGroup to finance R&D projects and taking them to the level where clinical trials may start. The R&D will use PLN 27mn of the share issue proceeds, with the remaining amount to be used for takeovers of small biotech firms.